Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Greil

Showing results (171-180 of 483) with videos related to

Pageof 49
Sort By:
Wiener Klinische Wochenschrift|January 21, 2014
Human immunodeficiency virus type 2 infections in AustriaNinon Taylor, Jan Marco Kern, Wolfgang Prammer, et al.
Leukemia|September 29, 2018
Exome sequencing of the TCL1 mouse model for CLL reveals genetic heterogeneity and dynamics during disease developmentNadja Zaborsky, Franz J Gassner, Jan P Höpner, et al.
Leukemia Research|August 4, 2004
Elevated levels of soluble CD44 are associated with advanced disease and in vitro proliferation of neoplastic lymphocytes in B-cell chronic lymphocytic leukaemiaWolfgang Eisterer, Oliver Bechter, Ola Söderberg, et al.
Annals of Surgical Oncology|December 31, 2011
Prognostic value of number of removed lymph nodes, number of involved lymph nodes, and lymph node ratio in 7502 breast cancer patients enrolled onto trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)Christoph Tausch, Susanne Taucher, Peter Dubsky, et al.
Journal of Neuro-Oncology|June 28, 2011
Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastasesNancy U Lin, Wolfgang Eierman, Richard Greil, et al.
Targeted Oncology|October 27, 2019
Therapy Line and Associated Predictors of Response to PD-1/PD-L1-Inhibitor Monotherapy in Advanced Non-small-Cell Lung Cancer: A Retrospective Bi-centric Cohort StudyDavid Lang, Florian Huemer, Gabriel Rinnerthaler, et al.
Anticancer Research|September 15, 2019
Treatment Algorithm for Patients With Gastric Adenocarcinoma: An Austrian Consensus on Systemic TherapyEwald Wöll, Wolfgang Eisterer, Armin Gerger, et al.
Cancer|October 21, 2006
Routine clinical use of alemtuzumab in patients with heavily pretreated B-cell chronic lymphocytic leukemia: a nation-wide retrospective study in AustriaMichael Fiegl, Andreas Falkner, Georg Hopfinger, et al.
Theranostics|May 4, 2018
DNA Methylation Signatures Predicting Bevacizumab Efficacy in Metastatic Breast CancerSimon Peter Gampenrieder, Gabriel Rinnerthaler, Hubert Hackl, et al.
Frontiers in Oncology|August 10, 2023
Management of metastatic colorectal cancer in patients ≥70 years - a single center experienceFlorian Huemer, Celine Dunkl, Gabriel Rinnerthaler, et al.
Pageof 49

Showing results (171-180 of 483) with videos related to

Sort By:
Pageof 49
Wiener Klinische Wochenschrift|January 21, 2014
Human immunodeficiency virus type 2 infections in AustriaNinon Taylor, Jan Marco Kern, Wolfgang Prammer, et al.
Leukemia|September 29, 2018
Exome sequencing of the TCL1 mouse model for CLL reveals genetic heterogeneity and dynamics during disease developmentNadja Zaborsky, Franz J Gassner, Jan P Höpner, et al.
Leukemia Research|August 4, 2004
Elevated levels of soluble CD44 are associated with advanced disease and in vitro proliferation of neoplastic lymphocytes in B-cell chronic lymphocytic leukaemiaWolfgang Eisterer, Oliver Bechter, Ola Söderberg, et al.
Annals of Surgical Oncology|December 31, 2011
Prognostic value of number of removed lymph nodes, number of involved lymph nodes, and lymph node ratio in 7502 breast cancer patients enrolled onto trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)Christoph Tausch, Susanne Taucher, Peter Dubsky, et al.
Journal of Neuro-Oncology|June 28, 2011
Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastasesNancy U Lin, Wolfgang Eierman, Richard Greil, et al.
Targeted Oncology|October 27, 2019
Therapy Line and Associated Predictors of Response to PD-1/PD-L1-Inhibitor Monotherapy in Advanced Non-small-Cell Lung Cancer: A Retrospective Bi-centric Cohort StudyDavid Lang, Florian Huemer, Gabriel Rinnerthaler, et al.
Anticancer Research|September 15, 2019
Treatment Algorithm for Patients With Gastric Adenocarcinoma: An Austrian Consensus on Systemic TherapyEwald Wöll, Wolfgang Eisterer, Armin Gerger, et al.
Cancer|October 21, 2006
Routine clinical use of alemtuzumab in patients with heavily pretreated B-cell chronic lymphocytic leukemia: a nation-wide retrospective study in AustriaMichael Fiegl, Andreas Falkner, Georg Hopfinger, et al.
Theranostics|May 4, 2018
DNA Methylation Signatures Predicting Bevacizumab Efficacy in Metastatic Breast CancerSimon Peter Gampenrieder, Gabriel Rinnerthaler, Hubert Hackl, et al.
Frontiers in Oncology|August 10, 2023
Management of metastatic colorectal cancer in patients ≥70 years - a single center experienceFlorian Huemer, Celine Dunkl, Gabriel Rinnerthaler, et al.
Pageof 49